|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/24 | |
| C12N 15/13 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 29/00 | |||
| A61P 19/02 | |||
| A61P 37/02 | |||
| G01N 33/68 | |||
| G01N 33/577 |
| (11) | Patento numeris | 3178847 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15830493.1 |
| Europos patento paraiškos padavimo data | 2015-03-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-06-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2015/074528 |
| Data | 2015-03-18 |
| (87) | Numeris | WO 2016/019726 |
| Data | 2016-02-11 |
| (30) | Numeris | Data | Šalis |
| 201410390493 | 2014-08-08 | CN |
| (72) |
SUN, Le, CN
ZHANG, Xiaogang, CN
LI, Maohua, CN
ZHANG, Cuijuan, CN
|
| (73) |
Abmax Biotechnology Co., Ltd,
99 Kechuang 14th Street Building 18, Unit 2, Suite 201 BDA, Beijing 101111,
CN
|
| (54) | ANTI-TNF-ALPHA FULLY HUMAN MONOCLONAL ANTIBODIES WITH LOW IMMUNOGENICITY AND APPLICATION THEREOF |
| ANTI-TNF-ALPHA FULLY HUMAN MONOCLONAL ANTIBODIES WITH LOW IMMUNOGENICITY AND APPLICATION THEREOF |